• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与静脉导管血流速度相关的脐动脉舒张末期血流缺失和逆转的宫内生长受限胎儿心钠肽水平。

Natriuretic peptide levels in intrauterine growth-restricted fetuses with absent and reversed end-diastolic flow of the umbilical artery in relation to ductus venosus flow velocities.

机构信息

Department of Obstetrics and Gynecology, Bürgerhospital Frankfurt, Frankfurt, Germany.

出版信息

J Perinat Med. 2011 Sep;39(5):529-37. doi: 10.1515/jpm.2011.065.

DOI:10.1515/jpm.2011.065
PMID:21892902
Abstract

OBJECTIVE

To determine if changes in natriuretic peptide levels [propeptide of atrial natriuretic peptide (proANP) and N-terminal propeptide of brain natriuretic peptide (NT-proBNP)] can be demonstrated in fetuses with serious growth restriction and Doppler ultrasonographic findings of hemodynamic compromise.

METHOD

Natriuretic peptides of the umbilical vein (proANP and NT-proBNP), arterial and venous blood gases, as well as lactate levels of the umbilical vein were determined in 38 appropriate for gestational age (AGA) fetuses, and 24 intrauterine growth-restricted (IUGR) fetuses with absent (zero-flow) and 17 IUGR fetuses with reversed end-diastolic flow (reverse-flow) of the umbilical artery.

RESULTS

A continuous increase in natriuretic peptides in the presence of progressive deterioration was shown. ANP concentrations were significantly lower in the AGA group (mean 818 fmol/mL; range 508-991 fmol/mL) than the zero-flow group (mean 19,680 fmol/mL; range 13,680-25,080 fmol/mL) and the reverse-flow group (mean 33,880 fmol/mL; range 24,365-41,786 fmol/mL). Significant differences were further demonstrated in BNP concentrations of the AGA group (mean 32 fmol/L; range 25-38 fmol/L), zero-flow group (mean 1191 fmol/L; range 908-1655 fmol/L), and reverse-flow group (mean 3063 fmol/L; range 1281-4968 fmol/L). Additionally, significant differences in lactate concentrations were observed for the three groups: AGA, 2.6 mmol/L (range 2-3 mmol/L); zero-flow group, 4.1 mmol/L (range 3.3-5 mmol/L); and reverse-flow group, 7.7 mmol/L (range 5.9-13.7 mmol/L). Increased ANP levels correlated with the arterial base excess and lactate concentrations, as well as with the flow velocities in the ductus venosus during atrial contraction (a-wave), and both ductus venosus indices (S-a)/D and (S-a)/V(mean). No correlations were established for BNP.

CONCLUSIONS

As components of a compensatory mechanism, natriuretic peptides exert an influence on the cardiovascular function of the fetus.

摘要

目的

确定严重生长受限胎儿及存在血流动力学障碍多普勒超声表现的胎儿能否检测到利钠肽水平(心钠肽前体(proANP)和脑钠肽 N 端前体(NT-proBNP))的变化。

方法

对 38 例适于胎龄(AGA)胎儿和 24 例宫内生长受限(IUGR)胎儿(其中脐动脉无血流(零流)17 例,脐动脉反向舒张末期血流(反向流)17 例)的脐静脉(proANP 和 NT-proBNP)、动静脉血气及脐静脉血乳酸水平进行了测定。

结果

研究表明,随着病情的恶化,利钠肽水平持续升高。AGA 组(818 皮摩尔/毫升;508-991 皮摩尔/毫升)的 ANP 浓度显著低于零流组(19680 皮摩尔/毫升;13680-25080 皮摩尔/毫升)和反向流组(33880 皮摩尔/毫升;24365-41786 皮摩尔/毫升)。AGA 组(32 皮摩尔/升;25-38 皮摩尔/升)、零流组(1191 皮摩尔/升;908-1655 皮摩尔/升)和反向流组(3063 皮摩尔/升;1281-4968 皮摩尔/升)的 BNP 浓度也有显著差异。三组的乳酸浓度也有显著差异:AGA 组为 2.6mmol/L(2-3mmol/L);零流组为 4.1mmol/L(3.3-5mmol/L);反向流组为 7.7mmol/L(5.9-13.7mmol/L)。ANP 水平升高与动脉碱剩余和乳酸浓度以及心房收缩时的静脉导管血流速度(a 波)和静脉导管指数(S-a)/D 和(S-a)/Vmean 相关。未发现 BNP 与上述指标相关。

结论

作为一种代偿机制的组成部分,利钠肽对胎儿心血管功能产生影响。

相似文献

1
Natriuretic peptide levels in intrauterine growth-restricted fetuses with absent and reversed end-diastolic flow of the umbilical artery in relation to ductus venosus flow velocities.与静脉导管血流速度相关的脐动脉舒张末期血流缺失和逆转的宫内生长受限胎儿心钠肽水平。
J Perinat Med. 2011 Sep;39(5):529-37. doi: 10.1515/jpm.2011.065.
2
Hematological changes in severe early onset growth-restricted fetuses with absent and reversed end-diastolic flow in the umbilical artery.脐动脉舒张末期血流消失及逆流的重度早发性生长受限胎儿的血液学变化
J Perinat Med. 2017 Apr 1;45(3):367-373. doi: 10.1515/jpm-2016-0240.
3
Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis.在妊娠 34 周前脐动脉和/或静脉导管无舒张末期血流或出现反向血流的生长受限胎儿中胎儿死亡的风险:系统评价和荟萃分析。
Am J Obstet Gynecol. 2018 Feb;218(2S):S774-S782.e21. doi: 10.1016/j.ajog.2017.11.566. Epub 2017 Dec 9.
4
Cardiovascular hemodynamics and umbilical artery N-terminal peptide of proB-type natriuretic peptide in human fetuses with growth restriction.生长受限胎儿的心血管血流动力学与脐动脉B型利钠肽原N端肽
Ultrasound Obstet Gynecol. 2007 Mar;29(3):296-303. doi: 10.1002/uog.3934.
5
Atrial natriuretic peptide levels in fetal blood in relation to inferior vena cava velocity waveforms.胎儿血液中的心钠素水平与下腔静脉血流速度波形的关系。
Obstet Gynecol. 1997 Feb;89(2):242-7. doi: 10.1016/S0029-7844(96)00432-2.
6
Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction.胎儿生长受限中动脉和静脉多普勒与围产期结局的关系
Ultrasound Obstet Gynecol. 2000 Oct;16(5):407-13. doi: 10.1046/j.1469-0705.2000.00284.x.
7
Arterial and ductus venosus Doppler in fetuses with absent or reverse end-diastolic flow in the umbilical artery: correlation with short-term perinatal outcome.脐动脉舒张末期血流缺失或反向的胎儿的动脉和静脉导管多普勒检查:与短期围产期结局的相关性
Acta Obstet Gynecol Scand. 2002 Sep;81(9):860-6. doi: 10.1034/j.1600-0412.2002.810911.x.
8
Alterations in time intervals of ductus venosus and atrioventricular flow velocity waveforms in growth-restricted fetuses.生长受限胎儿静脉导管和房室瓣血流速度波形时间间期的改变。
Ultrasound Obstet Gynecol. 2015 Aug;46(2):221-6. doi: 10.1002/uog.14717.
9
Simultaneous measurements of umbilical venous, fetal hepatic, and ductus venosus blood flow in growth-restricted human fetuses.对生长受限的人类胎儿的脐静脉、胎儿肝脏和静脉导管血流进行同步测量。
Am J Obstet Gynecol. 2004 May;190(5):1347-58. doi: 10.1016/j.ajog.2003.11.018.
10
Neonatal nucleated red blood cell counts in growth-restricted fetuses: relationship to arterial and venous Doppler studies.生长受限胎儿的新生儿有核红细胞计数:与动脉和静脉多普勒研究的关系。
Am J Obstet Gynecol. 1999 Jul;181(1):190-5. doi: 10.1016/s0002-9378(99)70458-8.

引用本文的文献

1
Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment.胎儿 NT-proBNP 水平及其在宫内治疗严重贫血期间的变化。
Arch Gynecol Obstet. 2024 Apr;309(4):1341-1351. doi: 10.1007/s00404-023-07006-8. Epub 2023 Mar 26.
2
Maternal Low Volume Circulation Relates to Normotensive and Preeclamptic Fetal Growth Restriction.母体低血容量循环与血压正常及子痫前期胎儿生长受限有关。
Front Med (Lausanne). 2022 Jun 9;9:902634. doi: 10.3389/fmed.2022.902634. eCollection 2022.
3
Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
影响早产儿 N 端脑利钠肽前体水平的因素及其在动脉导管未闭血流动力学意义判断中的应用。
Eur J Pediatr. 2018 Apr;177(4):521-532. doi: 10.1007/s00431-018-3089-y. Epub 2018 Jan 19.
4
N-terminal pro-B-type natriuretic peptide in amniotic fluid of fetuses with known or suspected cardiac load.已知或疑似存在心脏负荷的胎儿羊水中的N末端前B型利钠肽
PLoS One. 2017 May 18;12(5):e0177253. doi: 10.1371/journal.pone.0177253. eCollection 2017.
5
Intrauterine growth restriction: impact on cardiovascular development and function throughout infancy.宫内生长受限:对婴儿期心血管发育和功能的影响
Pediatr Res. 2016 Jun;79(6):821-30. doi: 10.1038/pr.2016.24. Epub 2016 Feb 11.
6
Reference intervals for N-terminal pro-B-type natriuretic peptide in amniotic fluid between 10 and 34 weeks of gestation.妊娠10至34周羊水N末端B型利钠肽原的参考区间
PLoS One. 2014 Dec 9;9(12):e114416. doi: 10.1371/journal.pone.0114416. eCollection 2014.